The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $31.42

Today's change-0.03 -0.10%
Updated December 24 1:01 PM EST. Delayed by at least 15 minutes.
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $31.42

Today's change-0.03 -0.10%
Updated December 24 1:01 PM EST. Delayed by at least 15 minutes.

Pfizer Inc down slightly

Pfizer Inc closed down just (U.S.)$0.03 Wednesday to (U.S.)$31.42. Over the last five days, shares have gained 0.96%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 9.83% during the last year.

Key company metrics

  • Open(U.S.) $31.44
  • Previous close(U.S.) $31.45
  • High(U.S.) $31.65
  • Low(U.S.) $31.40
  • Bid / Ask-- / --
  • YTD % change+2.58%
  • Volume10,823,030
  • Average volume (10-day)27,883,811
  • Average volume (1-month)26,923,744
  • Average volume (3-month)25,970,460
  • 52-week range(U.S.) $27.51 to (U.S.) $33.12
  • Beta0.69
  • Trailing P/E19.87×
  • P/E 1 year forward13.97×
  • Forward PEG10.34×
  • Indicated annual dividend(U.S.) $1.12
  • Dividend yield3.56%
  • Trailing EPS(U.S.) $1.58
Updated December 24 1:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+20.97%

Based on its net profit margin of 20.97%, Pfizer Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 28, 201409/28/2014Jun 29, 201406/29/2014Mar 30, 201403/30/2014Dec 31, 201312/31/2013
Revenue12,36112,77311,35351,584
Total other revenue--------
Total revenue12,36112,77311,35351,584
Gross profit9,99310,3279,31442,229
Total cost of revenue2,3682,4462,0399,355
Total operating expense8,6218,5998,44035,428
Selling / general / administrative3,5433,5203,04014,191
Research & development1,8021,7591,6236,551
Depreciation / amortization9721,0011,1174,599
Interest expense (income), net operating--------
Unusual expense (income)265958731,057
Other operating expenses, total-329-222-252-325
Operating income3,7404,1742,91316,156
Interest income (expense), net non-operating-343-343-321-1,414
Gain (loss) on sale of assets5333181320
Other--------
Income before tax3,5874,0032,84715,716
Income after tax2,6762,9212,26511,410
Income tax, total9111,0825824,306
Net income2,6672,9122,32922,003
Total adjustments to net income-1-10-2
Net income before extra. items2,6702,9122,25611,380
Minority interest-6-9-9-30
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,6692,9112,25611,378
Inc. avail. to common incl. extra. items2,6662,9112,32922,001
Diluted net income2,6662,9122,32922,003
Dilution adjustment--1--2
Diluted weighted average shares6,4036,4446,4766,895
Diluted EPS excluding extraordinary itemsvalue per share0.420.450.351.65
Dividends per sharevalue per share0.260.260.260.96
Diluted normalized EPSvalue per share0.450.450.451.73